Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Completed 4Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Observational 4Interventional 3

Sponsor

Conditions

Arthritis, Rheumatoid 5Spondylarthropathies 1Spondylarthritis 1Inflammatory Bowel Diseases 1Infections 1Cardiovascular Diseases 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2384Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1831Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1016Vincristine 964Cetuximab 945Trastuzumab 944Prednisone 941Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Tumor Necrosis Factor Inhibitors × Clear all
NCT06601595 2024-09-19

Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital

Assiut University

Not yet recruiting
100 enrolled

Inflammatory Bowel Diseases, Spondylarthropathies

NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

NCT04529902 2021-11-23

DREAM

Brigham and Women's Hospital

Completed
63,013 enrolled

Arthritis, Rheumatoid

NCT04953871 2021-07-08

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Phase 4 Completed
31 enrolled

Spondylarthritis

NCT01548768 2020-11-27

RHYTHM

Columbia University

Phase 4 Completed
149 enrolled 15 charts

Arthritis, Rheumatoid, Cardiovascular Diseases

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT02862574 2018-06-27

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Gilead Sciences

Phase 2 Terminated
15 enrolled 11 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡